Extensively drug-resistant ESBL-producing enterobacterales and coexisting antimicrobial resistance genes are associated with mortality in critically ill patients with cancer
Abstract
ESBL-producing bacteria are a problem in patients with cancer. The emergence of XDR phenotypes with ESBLs increases mortality. We aimed to evaluate ESBL-producing bacteria, the prevalence of MDR and XDR phenotypes, ESBL genes, and mortality predictors in patients with cancer in the ICU. Different clinical cultures were collected from patients in oncology ICUs. We used the VITEK2 system to identify isolates and assess antibiotic sensitivity, and the combination disk method to detect ESBL phenotypes. β-lactamase, ESBL, and carbapenem genes were detected using PCR. 136 isolates were ESBL-producing. Respiratory cultures were the main source, followed by blood cultures. K. pneumoniae was the most common, followed by E. coli. Isolates showed high resistance to third- and fourth-generation cephalosporins and carbapenem antibiotics. 84.6% and 13.2% of isolates were XDR and MDR, respectively. The most harbored genes were SHV and TEM (94.1%), CTXM-15 (59.6%), SHV-12 (67.6%), and NDM (78.7%). 38.2% of isolates harbored seven β-lactamase, ESBL, and carbapenem genes. K. pneumoniae significantly harbored more ESBL and carbapenem genes than E. coli. Patient age, relapses, and hospital stay are predictors of mortality in patients. An improved surveillance program and antibiotic stewardship are urgently needed.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.